Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia

NCT01472289 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

OTHER: Autologous Bone Marrow Mononuclear cells (BMMNCs)

Sponsor

TotipotentSC Scientific Product Pvt. Ltd.

Collaborators

[object Object]